Explore the Global Vaginal and Vulval Inflammatory Diseases Treatment Market — Key Trends, Regional Growth, Top Players, and 10-Year Forecast from 2026 to 2036

Future Market Insights

Vaginal and Vulval Inflammatory Diseases Treatment Market

Key Insight

Vaginal and vulval inflammatory diseases treatment sales will grow through 2036, led by vaginal dryness at 28.6% of the indication segment in 2026. The market was valued at USD 3.31 billion in 2025 and is expected to reach USD 5.8 billion by 2036, creating an incremental opportunity of USD 2.30 billion.

April 28, 2026

Anurag Sharma

286 Pages

Cite this Report

Vaginal and Vulval Inflammatory Diseases Treatment Market

https://www.futuremarketinsights.com/reports/vaginal-and-vulval-inflammatory-treatment-market

License

Buy Now

Summary ToC Companies

Key Players

Alma Lasers Ltd
Alma Lasers Ltd. (Israel)
Almirall
Astellas Pharma Inc
BTL Group of Companies
Bayer
Hologic
Lutronic Corporation
Novo Nordisk A/S
The Vanguard Group
Theramex
ThermiGen LLC
Venus Concept Ltd
VenusConcept

Methodology

Member of

Greater New York Chamber of Commerce

Recognized by

Awarded by

SILVER STEVIE® WINNER

Asia Pacific Stevie Awards - 2023

BRONZE STEVIE® Award

20th annual IBAs

Quick Contact

Chat on Whatsapp + 44 20 3769 9709 + 1 347 918 3531 Contact By Email

Get Free Sample PDF

Vaginal and Vulval Inflammatory Diseases Treatment Market

Key Players

Similar Industry Reports